Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$7.20 – $10.47
12% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $75.4M | $73.4M | $60.0M | $69.6M | $85.2M | $102.4M | $103.2M | $97.6M |
| Cost of revenue | $67.7M | $67.2M | $59.7M | $64.3M | $83.2M | $95.8M | $94.2M | $90.3M |
| Gross profit | $7.7M | $6.1M | $298.4K | $5.3M | $2.0M | $6.7M | $8.9M | $7.2M |
| Gross margin | 10.2% | 8.3% | 0.5% | 7.7% | 2.4% | 6.5% | 8.7% | 7.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $4.5M | $3.4M | −$2.6M | $2.9M | −$1.5M | $3.2M | $5.1M | $3.2M |
| EBITDA | $8.2M | $7.3M | $1.2M | $10.4M | $2.6M | $7.9M | $5.9M | $7.7M |
| Net income | $3.8M | $4.2M | −$2.0M | $7.0M | −$7.7M | $1.0M | −$906.4K | $1.6M |
| Net margin | 5.1% | 5.7% | -3.4% | 10.1% | -9.1% | 1.0% | -0.9% | 1.7% |
| EPS (diluted) | 2.78 | 3.04 | -1.47 | 5.07 | -5.60 | 0.75 | -0.66 | 1.18 |
Annual figures · source: Financial Modeling Prep
FEDERAL SCREW WORKS
No one on the platform currently holds FSCR.
No tracked institution reports a position in FSCR as of their last filing.
| Execution date | Ratio |
|---|---|
| 2003-04-02 | 9-for-4 |
No one on the platform has traded FSCR yet.
| $13M |
| — |
| LDDFFLiberty Defense Holdings, Ltd. | $5.21 | +2.00% | $5M | — |
| PRBCFPrecise Biometrics AB (publ) | $0.18 | +0.00% | $14M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.1× sales vs its 0.1× historical median P/S.
Fair value ≈ $6.75 · price $7.60 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.